Horn D, Fitzpatrick W C, Gompper P T, Ochs V, Bolton-Hansen M, Zarling J, Malik N, Todaro G J, Linsley P S
Oncogen, Seattle, Washington 98121.
Growth Factors. 1990;2(2-3):157-65. doi: 10.3109/08977199009071502.
Oncostatin M is a novel growth regulator originally isolated from differentiated human histiocytic lymphoma cells and activated T-lymphocytes based on its ability to inhibit the growth of A375 melanoma cells. We report here that oncostatin M is a widely acting regulator which alters the growth and/or morphology of cells derived from a variety of cancer cell types. At picomolar concentrations, recombinant oncostatin M inhibited the growth of 13/24 tumor cell lines. Six out of 7 lung cancer cell lines were inhibited by oncostatin M, but none of 6 colon cancer cell lines were affected. Oncostatin M also stimulated the growth of some normal cells (3/6), indicating that it, like many growth regulators, is bifunctional. Oncostatin M receptors appear necessary but not sufficient for a growth response to oncostatin M, since none of the cell lines lacking receptor responded to oncostatin M, whereas many but not all cell lines with receptor responded to oncostatin M. Receptor size (Mr congruent to 150,000) was similar for cells in which growth was inhibited, stimulated, or unaffected by oncostatin M.
抑瘤素M是一种新型生长调节因子,最初是从分化的人组织细胞淋巴瘤细胞和活化的T淋巴细胞中分离出来的,基于其抑制A375黑色素瘤细胞生长的能力。我们在此报告,抑瘤素M是一种广泛作用的调节因子,可改变源自多种癌细胞类型的细胞的生长和/或形态。在皮摩尔浓度下,重组抑瘤素M抑制了24种肿瘤细胞系中的13种的生长。7种肺癌细胞系中有6种被抑瘤素M抑制,但6种结肠癌细胞系均未受影响。抑瘤素M还刺激了一些正常细胞(6种中的3种)的生长,表明它与许多生长调节因子一样具有双功能。抑瘤素M受体对于对抑瘤素M的生长反应似乎是必要的,但不是充分的,因为缺乏受体的细胞系中没有一个对抑瘤素M有反应,而许多但不是所有具有受体的细胞系对抑瘤素M有反应。对于生长被抑瘤素M抑制、刺激或未受影响的细胞,受体大小(Mr约为150,000)相似。